211 related articles for article (PubMed ID: 19625524)
1. More than a retrograde messenger: nitric oxide needs two cGMP pathways to induce hippocampal long-term potentiation.
Taqatqeh F; Mergia E; Neitz A; Eysel UT; Koesling D; Mittmann T
J Neurosci; 2009 Jul; 29(29):9344-50. PubMed ID: 19625524
[TBL] [Abstract][Full Text] [Related]
2. Postsynaptic NO/cGMP increases NMDA receptor currents via hyperpolarization-activated cyclic nucleotide-gated channels in the hippocampus.
Neitz A; Mergia E; Imbrosci B; Petrasch-Parwez E; Eysel UT; Koesling D; Mittmann T
Cereb Cortex; 2014 Jul; 24(7):1923-36. PubMed ID: 23448871
[TBL] [Abstract][Full Text] [Related]
3. On the role of nitric oxide in hippocampal long-term potentiation.
Bon CL; Garthwaite J
J Neurosci; 2003 Mar; 23(5):1941-8. PubMed ID: 12629199
[TBL] [Abstract][Full Text] [Related]
4. Presynaptic nitric oxide/cGMP facilitates glutamate release via hyperpolarization-activated cyclic nucleotide-gated channels in the hippocampus.
Neitz A; Mergia E; Eysel UT; Koesling D; Mittmann T
Eur J Neurosci; 2011 May; 33(9):1611-21. PubMed ID: 21410795
[TBL] [Abstract][Full Text] [Related]
5. Long-term potentiation in the visual cortex requires both nitric oxide receptor guanylyl cyclases.
Haghikia A; Mergia E; Friebe A; Eysel UT; Koesling D; Mittmann T
J Neurosci; 2007 Jan; 27(4):818-23. PubMed ID: 17251421
[TBL] [Abstract][Full Text] [Related]
6. Long-term potentiation in hippocampus involves sequential activation of soluble guanylate cyclase, cGMP-dependent protein kinase, and cGMP-degrading phosphodiesterase.
Monfort P; Muñoz MD; Kosenko E; Felipo V
J Neurosci; 2002 Dec; 22(23):10116-22. PubMed ID: 12451112
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide/cGMP signaling via guanylyl cyclase isoform 1 modulates glutamate and GABA release in somatosensory cortex of mice.
Wang Q; Mergia E; Koesling D; Mittmann T
Neuroscience; 2017 Sep; 360():180-189. PubMed ID: 28782641
[TBL] [Abstract][Full Text] [Related]
8. Sequential activation of soluble guanylate cyclase, protein kinase G and cGMP-degrading phosphodiesterase is necessary for proper induction of long-term potentiation in CA1 of hippocampus. Alterations in hyperammonemia.
Monfort P; Muñoz MD; Kosenko E; Llansola M; Sánchez-Pérez A; Cauli O; Felipo V
Neurochem Int; 2004 Nov; 45(6):895-901. PubMed ID: 15312984
[TBL] [Abstract][Full Text] [Related]
9. Tonic and phasic nitric oxide signals in hippocampal long-term potentiation.
Hopper RA; Garthwaite J
J Neurosci; 2006 Nov; 26(45):11513-21. PubMed ID: 17093072
[TBL] [Abstract][Full Text] [Related]
10. Genetic mouse models of the NO receptor 'soluble' guanylyl cyclases.
Mergia E; Koesling D; Friebe A
Handb Exp Pharmacol; 2009; (191):33-46. PubMed ID: 19089324
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide and carbon monoxide as possible retrograde messengers in hippocampal long-term potentiation.
Hawkins RD; Zhuo M; Arancio O
J Neurobiol; 1994 Jun; 25(6):652-65. PubMed ID: 8071665
[TBL] [Abstract][Full Text] [Related]
12. Hyperammonemia impairs long-term potentiation in hippocampus by altering the modulation of cGMP-degrading phosphodiesterase by protein kinase G.
Monfort P; Muñoz MD; Felipo V
Neurobiol Dis; 2004 Feb; 15(1):1-10. PubMed ID: 14751765
[TBL] [Abstract][Full Text] [Related]
13. Exogenous nitric oxide causes potentiation of hippocampal synaptic transmission during low-frequency stimulation via the endogenous nitric oxide-cGMP pathway.
Bon CL; Garthwaite J
Eur J Neurosci; 2001 Aug; 14(4):585-94. PubMed ID: 11556884
[TBL] [Abstract][Full Text] [Related]
14. Activity-dependent long-term enhancement of transmitter release by presynaptic 3',5'-cyclic GMP in cultured hippocampal neurons.
Arancio O; Kandel ER; Hawkins RD
Nature; 1995 Jul; 376(6535):74-80. PubMed ID: 7596438
[TBL] [Abstract][Full Text] [Related]
15. Presynaptic and postsynaptic roles of NO, cGK, and RhoA in long-lasting potentiation and aggregation of synaptic proteins.
Wang HG; Lu FM; Jin I; Udo H; Kandel ER; de Vente J; Walter U; Lohmann SM; Hawkins RD; Antonova I
Neuron; 2005 Feb; 45(3):389-403. PubMed ID: 15694326
[TBL] [Abstract][Full Text] [Related]
16. Role of guanylyl cyclase and cGMP-dependent protein kinase in long-term potentiation.
Zhuo M; Hu Y; Schultz C; Kandel ER; Hawkins RD
Nature; 1994 Apr; 368(6472):635-9. PubMed ID: 7908417
[TBL] [Abstract][Full Text] [Related]
17. Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP-responsive element-binding protein pathway during hippocampal synaptic plasticity.
Puzzo D; Vitolo O; Trinchese F; Jacob JP; Palmeri A; Arancio O
J Neurosci; 2005 Jul; 25(29):6887-97. PubMed ID: 16033898
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide and cGMP can produce either synaptic depression or potentiation depending on the frequency of presynaptic stimulation in the hippocampus.
Zhuo M; Kandel ER; Hawkins RD
Neuroreport; 1994 May; 5(9):1033-6. PubMed ID: 8080953
[TBL] [Abstract][Full Text] [Related]
19. Examination of the role of cGMP in long-term potentiation in the CA1 region of the hippocampus.
Selig DK; Segal MR; Liao D; Malenka RC; Malinow R; Nicoll RA; Lisman JE
Learn Mem; 1996; 3(1):42-8. PubMed ID: 10456075
[TBL] [Abstract][Full Text] [Related]
20. An ADP-ribosyltransferase as a potential target for nitric oxide action in hippocampal long-term potentiation.
Schuman EM; Meffert MK; Schulman H; Madison DV
Proc Natl Acad Sci U S A; 1994 Dec; 91(25):11958-62. PubMed ID: 7991564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
